Jennifer Bright's most recent trade in Biolase Inc was a trade of 58,000 Restricted Stock Unit done . Disclosure was reported to the exchange on June 2, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Biolase Inc | Jennifer Bright | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 58,000 | 90,563 | - | - | Restricted Stock Unit | |
Biolase Inc | Jennifer Bright | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 58,000 | 90,563 | - | - | Restricted Stock Unit | |
Biolase Inc | Jennifer Bright | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 10,000 | 25,900 | - | - | Restricted Stock Unit | |
Biolase Inc | Jennifer Bright | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 6,663 | 32,563 | - | - | Restricted Stock Unit |